Total Payments
$8,929
2024 Payments
$4,797
Companies
16
Transactions
59
Medicare Patients
7,543
Medicare Billing
$3.1M
Payment Breakdown by Category
Travel$2,883 (32.3%)
Consulting$2,820 (31.6%)
Food & Beverage$2,650 (29.7%)
Other$577.00 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,883 | 6 | 32.3% |
| Consulting Fee | $2,820 | 1 | 31.6% |
| Food and Beverage | $2,650 | 51 | 29.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $577.00 | 1 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,286 | 9 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $1,733 | 4 | $0 (2019) |
| Roche TCRC, Inc. | $1,500 | 3 | $0 (2020) |
| Apellis Pharmaceuticals, Inc. | $775.79 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $631.03 | 13 | $0 (2024) |
| Notal Vision, Inc. | $208.96 | 7 | $0 (2024) |
| Coherus Biosciences Inc. | $149.99 | 1 | $0 (2023) |
| EyePoint Pharmaceuticals US, Inc. | $137.59 | 2 | $0 (2023) |
| Allergan Inc. | $125.50 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $95.70 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,797 | 34 | Genentech USA, Inc. ($3,137) |
| 2023 | $516.74 | 9 | Coherus Biosciences Inc. ($149.99) |
| 2020 | $1,500 | 3 | Roche TCRC, Inc. ($1,500) |
| 2019 | $1,972 | 11 | Regeneron Pharmaceuticals, Inc. ($1,733) |
| 2018 | $143.67 | 2 | Allergan Inc. ($125.50) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $38.33 | General |
| Category: Ophthalmology | ||||||
| 12/14/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $62.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/25/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 11/19/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $151.92 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $179.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $82.86 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $57.50 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Ophthalmology | ||||||
| 09/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $166.50 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/09/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/11/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Ophthalmology | ||||||
| 07/09/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Ophthalmology | ||||||
| 06/28/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,721 | 2,661 | $1.0M | $373,268 |
| 2022 | 19 | 2,942 | 10,529 | $3.1M | $1.7M |
| 2021 | 16 | 1,989 | 3,818 | $1.2M | $795,384 |
| 2020 | 13 | 891 | 1,281 | $461,139 | $240,082 |
Total Patients
7,543
Total Services
18,289
Medicare Billing
$3.1M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 63 | 304 | $393,120 | $206,272 | 52.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 289 | 295 | $70,661 | $25,874 | 36.6% |
| 92134 | Imaging of retina | Office | 2023 | 471 | 812 | $62,568 | $23,111 | 36.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 115 | 272 | $125,421 | $22,159 | 17.7% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 26 | 30 | $99,942 | $19,629 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 152 | $37,625 | $14,410 | 38.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 14 | $60,837 | $11,653 | 19.2% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $55,606 | $11,047 | 19.9% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $44,233 | $9,401 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 140 | $24,256 | $9,305 | 38.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 393 | 444 | $20,979 | $8,165 | 38.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 52 | 142 | $12,070 | $7,829 | 64.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 12 | 13 | $24,787 | $2,347 | 9.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 21 | 21 | $5,631 | $2,065 | 36.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 193 | 1,612 | $1.9M | $1.2M | 61.5% |
| J3490 | Unclassified drugs | Office | 2022 | 82 | 436 | $247,102 | $143,550 | 58.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 32 | 3,720 | $170,340 | $111,010 | 65.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 256 | 943 | $211,406 | $89,839 | 42.5% |
| 92134 | Imaging of retina | Office | 2022 | 710 | 1,644 | $89,985 | $47,727 | 53.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 425 | 505 | $101,529 | $44,467 | 43.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 19 | 176 | $119,870 | $37,130 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 350 | $48,248 | $22,843 | 47.3% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 26 | 32 | $42,473 | $20,513 | 48.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 197 | 197 | $43,636 | $18,194 | 41.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 15 | 15 | $26,460 | $13,553 | 51.2% |
About Dr. Jonathan Brugger, M.D
Dr. Jonathan Brugger, M.D is a Retina Specialist healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013172105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Brugger, M.D has received a total of $8,929 in payments from pharmaceutical and medical device companies, with $4,797 received in 2024. These payments were reported across 59 transactions from 16 companies. The most common payment nature is "Travel and Lodging" ($2,883).
As a Medicare-enrolled provider, Brugger has provided services to 7,543 Medicare beneficiaries, totaling 18,289 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Retina Specialist, Ophthalmology
- Location Sarasota, FL
- Active Since 07/28/2008
- Last Updated 09/03/2020
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1013172105
Products in Payments
- Vabysmo (Drug) $3,286
- Non-Covered Product (Drug) $1,500
- Syfovre (Drug) $775.79
- Izervay (Drug) $613.72
- Foresee Home (Device) $208.96
- Cimerli (Biological) $149.99
- YUTIQ (Drug) $137.59
- EVA Ophthalmic Surgical System (Device) $79.66
- Susvimo (Drug) $62.00
- XIPERE (Drug) $42.11
- BEOVU (Drug) $41.58
- TRAVATAN Z (Drug) $18.17
- ILUVIEN (Drug) $15.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Sarasota
Dr. Elizabeth Richter, M.d., Ph.d, M.D., PH.D
Retina Specialist — Payments: $15,224
Retina Specialist $15,224
Oren Plous, M.d, M.D
Retina Specialist — Payments: $3,026
Retina Specialist $3,026
Renelle Lim, M.d, M.D
Retina Specialist — Payments: $1,890
Retina Specialist $1,890
Dr. Christopher Stelton, Md, MD
Retina Specialist — Payments: $1,519
Retina Specialist $1,519
Dr. Robert Snyder, Md, MD
Retina Specialist — Payments: $1,294
Retina Specialist $1,294
Dr. Jie Sun, Md, MD
Retina Specialist — Payments: $166.91
Retina Specialist $166.91